Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xie Wu Capsule
- Development stage
- Phase 2
- Lead developer
- Shanghai University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Xie Wu Capsule is a traditional Chinese herbal medicine developed by Shanghai University of Traditional Chinese Medicine. It is primarily investigated for immune system and respiratory diseases, with a particular focus on asthma. The formulation and precise mechanism of action are not specified in the available sources, but as an herbal medicine, it likely contains multiple active plant-derived ingredients that may exert immunomodulatory or anti-inflammatory effects. Its highest reported clinical development status is "Pending," with at least one Phase 2 clinical trial conducted for bronchial asthma[1].
- Other names
- xie wu jiao nang
Beyond the preview
Go deeper on Xie Wu Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xie Wu Capsule.